Fuelled by media scrutiny, drug affordability is becoming an increasingly powerful influence in market access decisions today. Learn how to overcome it.
Lean Biotechs and patients themselves are using new technology to revolutionise the patient experience. In order to keep up, Pharma needs to significantly accelerate and strengthen its value proposition in the digital space.
Health Canada have drafted a guidance document relating to the planned public release of clinical trial documents, broadly in line with EMA Policy 0070. What are the key differences? How should your organisation prepare?
Plain language summaries of clinical study reports must be understood by lay readers and clinical experts. How should organisations strike the balance?
A recently announced FDA pilot program suggests that the agency is taking steps towards implementing an equivalent to the EMA's policy 0070. US-based organisations should act now to prepare.
With the Life Sciences industry playing catch-up on AI, how are industry leaders narrowing the gap? John Cogan, Head of innovation, shares his views.
Want to learn the most efficient way to run a clinical trial anonymisation project? Read our step-by-step guide to achieving EMA policy 0070 compliance.
Is your Biopharmaceutical organisation ready for GDPR? Read on to learn what steps you need to take to ensure compliance with the new regulation.